Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Data is not available at this time. Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Recursion Pharmaceuticals operates as a TechBio company, using its proprietary Recursion OS to automate biological experiments and analyze them with artificial intelligence. The company generates vast ...

On July 4, 2026, Vitalik Buterin published the most consequential Ethereum protocol document in four years: an updated "Lean Ethereum" strawmap that commits the world's second-largest blockchain to ...

Americans view class as not just determined by income, but also by attitudes and lifestyle choices. That was the takeaway of a recent Wall Street Journal survey that asked 2,000 people what economic ...

Learning to program in C on an online platform can provide structured learning and a certification to show along with your resume. Learning C can still be useful in 2026, especially if you want to ...

LaTeX is a system for high-quality technical typesetting. Most mathematicians and many other people use LaTeX to typeset papers, exams, books, and more. The LaTeX Project Home Page has additional ...

Americans view class as not just determined by income, but also by attitudes and lifestyle choices. That was the takeaway of a recent Wall Street Journal survey that asked 2,000 people what economic ...

Nine days into the longest commercial AI outage in history, two developments on Sunday are pulling in opposite directions — one suggesting Anthropic's most powerful public model may be closer to ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...